Dry powder cells and cell culture reagents and methods of production thereof
Abstract
The present invention relates generally to nutritive medium, medium supplement, media subgroup and buffer formulations. Specifically, powdered nutritive medium, supplement, subgroup formulations, cell culture media comprising all of the necessary nutritive factors for in vitro cell cultivation, buffer formulations that produce particular ionic and pH conditions upon reconstitution with a solvent are provided. Particularly, methods of production of these media, supplement, subgroup, buffer formulations and kits, and methods for the cultivation of prokaryotic and eukaryotic cells using these dry powdered nutritive media, supplement, subgroup and buffer formulations are provided. Methods of producing sterile, powdered media or supplement (e.g., powdered FBS, powdered transferrin, powdered insulin, powdered organ extracts, powdered growth factors), media subgroup and buffer formulations by gamma irradiation are provided. Methods for producing dry cell powders, comprising spray-drying a cell suspension, and cells, media, media supplement, media subgroup and buffer powders produced by these methods are provided.
Claims
exact text as granted — not AI-modified1 - 9 . (canceled)
92 . An agglomerated eukaryotic cell culture medium, wherein the medium is a complete media, a media subgroup, a supplement, or a buffer and wherein said medium has been sterilized using gamma irradiation.
93 . The medium of claim 92 , wherein the medium has been sterilized after packaging.
94 . The medium of claim 92 that is capable of culturing a eukaryotic cell after reconstitution with a solvent.
95 . The medium of claim 94 , and a eukaryotic cell.
96 . The medium of claim 95 wherein said cell is either a plant, animal or a yeast cell.
97 . The medium of claim 96 , wherein the animal cell is selected from the group consisting of CHO, 293, VERO, BHK, SP2/0, MDBK, COS, AE-1, L5.1, PER-C6, hybridoma cells and HeLa cells.
98 . The medium of claim 92 wherein the gamma irradiation is done at least 25 kGy for several days.
99 . The medium of claim 94 wherein the solvent is water.
100 . The medium of claim 94 wherein the solvent is an aqueous buffer.
101 . The medium of claim 98 wherein the gamma irradiation inactivates bacteria, fungi, spores and viruses present in the medium, supplement or buffer.
102 . A method of making the medium of claim 92 , comprising subjecting an agglomerated eukaryotic medium to gamma irradiation.
103 . The method of claim 102 wherein the inactivation renders the bacteria, fungi, spores and virus incapable of replication.
104 . The method of claim 103 wherein the gamma-irradiation is done at a total dosage of about 10-100 kGy.
105 . The method of claim 104 wherein the total dosage is about 15-75 kGy.
106 . The method of claim 104 wherein the total dosage is about 20-40 kGy.
107 . The method of claim 104 wherein the gamma-irradiation is done for about 1 hour to about 7 days, or for about 1 hour to about 5 days, or for about 1 hour to about 3 days, or for about 1 hour to about 24 hours.Join the waitlist — get patent alerts
Track US2013065300A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.